Items where Author is "Murray, RM"
 | Up a level |
NOTTAGE, J.F., STONE, J., MURRAY, R.M., SUMICH, A., BRAMON-BOSCH, E., FFYTCHE, D. and MORRISON, P.D., 2015. Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis. Psychopharmacology, 232 (3), pp. 519-528. ISSN 0033-3158
STONE, J.M., MORRISON, P.D., BRUGGER, S., NOTTAGE, J., BHATTACHARYYA, S., SUMICH, A., WILSON, D., TUNSTALL, N., FEILDING, A., BRENNEISEN, R., MCGUIRE, P., MURRAY, R.M. and FFYTCHE, D.H., 2012. Communication breakdown: delta-9 tetrahydrocannabinol effects on pre-speech neural coherence. Molecular Psychiatry, 17 (6), pp. 568-569. ISSN 1359-4184
MORRISON, P., NOTTAGE, J., STONE, J., BHATTACHARYYA, S., TUNSTALL, N., BRENNEISEN, R., HOLT, D., WILSON, D., SUMICH, A., MCGUIRE, P., MURRAY, R.M., KAPUR, S. and FFYTCHE, D.H., 2011. Disruption of frontal theta coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms. Neuropsychopharmacology, 36 (4), pp. 827-836. ISSN 0893-133X
PREMKUMAR, P., COOKE, M.A., FANNON, D., PETERS, E., MICHEL, T.M., MURRAY, R.M., KUIPERS, E. and KUMARI, V., 2008. Misattribution bias of threat-related facial expressions is related to a longer duration of illness and poor executive function in schizophrenia and schizoaffective disorder. European Psychiatry, 23, pp. 14-19.
